NEW YORK (AP) — U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind ...
Connecticut-based Pfizer Inc. said Thursday that it has completed the successful acquisition of Metsera, Inc., which is “a clinical-stage biopharmaceutical company accelerating the next generation of ...
Andrew Baum, a former Citi analyst, has left his role as Pfizer's executive vice president and chief strategy and innovation ...
Pfizer is paying over $7 billion to buy clinical-stage biotech Metsera. This gives it a wedge into the hottest segment of the pharma industry. Yet, shares of the giant drugmaker remain at depressed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results